Concomitant Versus Tailored Therapy Based on Antibiotic Resistance Profiles for <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis.

ITT Eradication Rates Meta‐analysis of 8 trials (2502 patients: 1318 tailored; 1184 concomitant) showed a borderline significant difference favoring tailored therapy (RR = 1.05; 95% CI: 1.00–1.10; p = 0.05; I 2 = 58%) (Figure 2 ).

also in 3,262 other papers

83.2%; RR = 1.05; 95% CI: 1.00–1.10; p = 0.054) that approached but narrowly missed statistical significance.

also in 104 other papers